ACR Alpine Capital Research Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Motors
GM
|
+$19.6M |
| 2 |
Vodafone
VOD
|
+$13.6M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$6.01M |
| 4 |
RFP
Resolute Forest Products Inc.
RFP
|
+$3.65M |
| 5 |
Liberty Latin America Class C
LILAK
|
+$2.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$80.3M |
| 2 |
Walmart Inc
WMT
|
+$79.1M |
| 3 |
JPMorgan Chase
JPM
|
+$18.3M |
| 4 |
TE Connectivity
TEL
|
+$1.13M |
| 5 |
Microsoft
MSFT
|
+$952K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.71% |
| 2 | Communication Services | 18.6% |
| 3 | Healthcare | 18.07% |
| 4 | Technology | 16.7% |
| 5 | Financials | 13.63% |
Similar funds
ACR Alpine Capital Research's Q1 2017 Portfolio in Review
As of Q1 2017, ACR Alpine Capital Research held 29 positions worth $1.16B, down 6% from $1.24B the previous quarter. Its ten largest holdings account for 85% of the portfolio.
ACR Alpine Capital Research withdrew a net $132M in Q1 2017, closing 3 positions and reducing 7 holdings. Its most notable exit was Walmart Inc, an estimated $79.1M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 20% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, ACR Alpine Capital Research opened a new position in Howard Hughes worth $2.22M.
- ACR Alpine Capital Research's largest Q1 2017 buy was Howard Hughes: 19,826 shares worth $2.22M.
- ACR Alpine Capital Research added most to General Motors in Q1 2017, an estimated $19.6M increase.
- ACR Alpine Capital Research's biggest Q1 2017 reduction was Merck, cutting an estimated $80.3M.
- ACR Alpine Capital Research fully exited Walmart Inc in Q1 2017, selling an estimated $79.1M.
- ACR Alpine Capital Research's ten largest holdings make up 85% of its $1.16B portfolio in Q1 2017.
- ACR Alpine Capital Research opened 2 new positions and closed 3 in Q1 2017.
- ACR Alpine Capital Research's portfolio value fell 6% quarter-over-quarter to $1.16B.
Based on ACR Alpine Capital Research's 13F filing for Q1 2017, filed 10 May 2017.